Regenicin, Inc.

Regenicin, Inc.verified

RGIN

Price:

$0.0001

Market Cap:

$15.35K

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.[Read more]

Industry

Biotechnology

IPO Date

2009-11-16

Stock Exchange

PNK

Ticker

RGIN

The Enterprise Value as of November 2024 (TTM) for Regenicin, Inc. (RGIN) is 15.35K

According to Regenicin, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.35K. This represents a change of -100.29% compared to the average of -5274139.05 of the last 4 quarters.

Regenicin, Inc. (RGIN) Historical Enterprise Value (quarterly & annually)

How has RGIN Enterprise Value performed in the past?

The mean historical Enterprise Value of Regenicin, Inc. over the last ten years is 3.63M. The current 15.35K Enterprise Value has changed -57.66% with respect to the historical average. Over the past ten years (40 quarters), RGIN's Enterprise Value was at its highest in in the March 2017 quarter at 21.60M. The Enterprise Value was at its lowest in in the December 2022 quarter at -11074241.47.

Quarterly (TTM)
Annual

Average

3.63M

Median

3.20M

Minimum

807.23K

Maximum

9.36M

Regenicin, Inc. (RGIN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Regenicin, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.14%

Maximum Annual Enterprise Value = 9.36M

Minimum Annual Increase = -69.50%

Minimum Annual Enterprise Value = 807.23K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20221.12M-69.50%
20213.67M51.76%
20202.42M-28.23%
20193.37M-39.29%
20185.55M-40.72%
20179.36M54.02%
20166.08M101.00%
20153.02M274.72%
2014807.23K-4.56%
2013845.83K3.14%

Regenicin, Inc. (RGIN) Average Enterprise Value

How has RGIN Enterprise Value performed in the past?

The current Enterprise Value of Regenicin, Inc. (RGIN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.40M

5-year avg

3.23M

10-year avg

3.63M

Regenicin, Inc. (RGIN) Enterprise Value vs. Peers

How is RGIN’s Enterprise Value compared to its peers?

Regenicin, Inc.’s Enterprise Value is less than Denali Therapeutics Inc. (3.52B), less than Cardiff Oncology, Inc. (113.93M), less than CytoDyn Inc. (144.53M), less than Onconova Therapeutics, Inc. (4.51M), greater than Inovio Pharmaceuticals, Inc. (-9135914000.00), less than ImmunoGen, Inc. (8.19B), less than Mustang Bio, Inc. (7.08M), less than Coya Therapeutics, Inc. (77.54M), less than REGENXBIO Inc. (502.58M), less than BridgeBio Pharma, Inc. (5.89B), less than Atea Pharmaceuticals, Inc. (188.01M), less than Krystal Biotech, Inc. (5.10B),

Build a custom stock screener for Regenicin, Inc. (RGIN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regenicin, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regenicin, Inc. (RGIN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regenicin, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Regenicin, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Regenicin, Inc. (RGIN)?

What is the 3-year average Enterprise Value for Regenicin, Inc. (RGIN)?

What is the 5-year average Enterprise Value for Regenicin, Inc. (RGIN)?

How does the current Enterprise Value for Regenicin, Inc. (RGIN) compare to its historical average?